Xylem ($XYL) board on Feb 25, 2026 approved a new, no‑expiration share repurchase program authorizing up…
Filed with the SEC on · Summarized by InvestorsBot
Xylem ($XYL) board on Feb 25, 2026 approved a new, no‑expiration share repurchase program authorizing up to $1.5B in common stock buybacks. Repurchases may be open‑market or otherwise; program can be suspended and carries no purchase obligation. 🔁💰 #Buyback #Xylem
Investor impact: $1.5B program increases potential capital return and could be EPS‑accretive, but timing, pace and funding not disclosed—repurchases are at company discretion. Monitor trading activity and future disclosures. 📈 $XYL #Investing #Buyback
8‑K filed Feb 25, 2026; filing signed by CFO William K. Grogan. Program gives board flexibility (no expiration, no mandated purchase amount). Watch for subsequent execution details. 📝 $XYL #SECfiling #Stocks